2016, Número 5
<< Anterior Siguiente >>
Ann Hepatol 2016; 15 (5)
How to screen NAFLD patients for diabetes?
González-Moreno EI, García-Compean D, González-González JA, Maldonado-Garza HJ
Idioma: Ingles.
Referencias bibliográficas: 4
Paginas: 801-802
Archivo PDF: 109.71 Kb.
FRAGMENTO
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, et al. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in nonoverweight individuals. Liver Int 2016; 36: 275-83.
Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-30.e1; quiz e60.
Koehler EM, Plompen EP, Schouten JN, Hansen BE, Darwish Murad S, Taimr P, Leebeek FW, et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. Hepatology 2016; 63: 138-47.
Manchanayake J, Chitturi S, Nolan C, Farrell GC. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2011; 26: 510-6.